4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-008513
EVP, R&D & Chief Scientific Of gave up 4,426 shares (to pay taxes)
- EVP, R&D & Chief Scientific Of acquired 17,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Haqq Christopher EVP, R&D & Chief Scientific Of | 2018-02-06 | Grant or award | +17,500 | 360,030 | D | ||
| Haqq Christopher EVP, R&D & Chief Scientific Of | 2018-02-06 | Shares withheld for taxes | −4,426 | $35.80 | $158,451 | 355,604 | D |
| Derivatives | |||||||
| Haqq Christopher EVP, R&D & Chief Scientific Of | 2018-02-06 | Grant or award · Employee Stock Option (Right to Buy) | +35,000 | 35,000 | D | ||
Loading xslF345X03/doc4.xml…